Today: 21 May 2026
Critical Metals stock flips lower after early surge as U.S. rare-earth deal jolts sector
26 January 2026
2 mins read

Critical Metals stock flips lower after early surge as U.S. rare-earth deal jolts sector

New York, January 26, 2026, 10:46 (EST) — Regular session

  • Critical Metals shares dropped roughly 9% after erasing an initial advance and swinging wildly within the first hour
  • Shares of rare-earth developers rose after Washington threw its support behind a fresh financing deal for USA Rare Earth
  • Traders want clarity on Critical Metals’ plans for Tanbreez, including its timeline and funding strategy in Greenland

Shares of Critical Metals Corp (CRML) tumbled 9.5% to $18.66 by 10:46 a.m. EST, after hitting an intraday peak of $22.59 and plunging to a low of $18.54. The stock kicked off at $21.81, edging past Friday’s $20.62 close, on roughly 17.7 million shares changing hands.

Washington’s push on rare earth supply chains is stirring up the market, with traders eyeing the smallest listed companies as high-beta plays. Rare earths, a set of 17 elements, are crucial for making high-strength magnets found in electric vehicles, smartphones, and military equipment.

Critical Metals, focused on developing the Tanbreez deposit in southern Greenland, has quickly turned into a barometer for that sector. With no commercial rare earth production underway, its stock remains highly sensitive to policy updates and financing rumors.

USA Rare Earth jumped about 15% after announcing the Trump administration’s backing of a $1.6 billion debt-and-equity package. This includes $277 million in proposed federal funding plus a $1.3 billion senior secured loan under the CHIPS Act to support building a Texas mine and a magnet plant in Oklahoma. The company also unveiled a $1.5 billion private investment in public equity (PIPE) priced at $21.50 per share. Washington has previously invested in MP Materials, Lithium Americas, and Trilogy Metals. CEO Barbara Humpton highlighted the key question: “What would be the cost of having access to nothing?” Reuters

The read-across boosted several rare-earth and critical-minerals stocks at the open, but the gains didn’t stick everywhere. In Critical Metals, what started as a rally soon flipped into a selloff.

Earlier this month, Critical Metals inked a non-binding term sheet with Saudi Arabia’s Tariq Abdel Hadi Abdullah Al-Qahtani & Brothers for a 50-50 joint venture. The deal aims to refine 25% of output from its planned Tanbreez project in the kingdom, the company confirmed. Tariq’s CEO, Abdulmalik Tariq Al-Qahtani, highlighted the “strong opportunity” to collaborate with U.S. customers. Critical Metals pegged the Greenland mine’s start-up costs at around $290 million, eyeing first production next year. Reuters

Investors remain caught between term sheets and actual completed plants. Many timelines in the sector hinge on permitting, funding, and offtake contracts—processes that often stretch out over years.

Still, U.S. support for USA Rare Earth remains only a proposal, while Critical Metals’ deal with Saudi Arabia is non-binding. Any drop in rare-earth prices, a tighter funding environment, or setbacks in Greenland could quickly turn sentiment negative.

Monday’s action demonstrated how quickly these trades can reverse. The stock started the day up but slipped lower as volume picked up.

Critical Metals revealed in its latest annual filing that Greenland has pushed back deadlines related to Tanbreez’s exploitation license. This includes the need to submit financial security and a company guarantee by June 30, 2026. That deadline—and any news on project financing before then—will be a key date for CRML investors.

Stock Market Today

  • Analysts Boost Broadcom Price Targets Despite Stock Dip
    May 20, 2026, 11:22 PM EDT. Broadcom (AVGO) shares fell 6.5% to $411.07 on May 19, retreating from a record high of $439.79 on May 14. Despite this drop, several major analysts raised their price targets. Wells Fargo lifted its target to $545 from $430, TD Cowen to $500 from $405, and UBS to $490 from $475, all maintaining buy ratings. Evercore ISI's Mark Lipacis, a top-ranked analyst, raised his target to $582, citing growing demand for Broadcom's custom AI chips amid shifts in AI workloads. Risks remain from semiconductor market volatility and geopolitical tensions impacting chip deals. Broadcom's strategic moves, including its VMware acquisition and partnerships with Google and Meta for AI-focused chips, position it well in enterprise infrastructure and AI growth.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Amazon stock price slips as AWS lands Nationwide deal and earnings loom
Previous Story

Amazon stock price slips as AWS lands Nationwide deal and earnings loom

Dow Jones today: Apple, Cisco lift the index as Fed decision and Big Tech earnings loom
Next Story

Dow Jones today: Apple, Cisco lift the index as Fed decision and Big Tech earnings loom

Go toTop